FDA takes action against Abbvie for misleading Ubrelvy ad with Serena Williams
The Food and Drug Administration (FDA) has recently intervened regarding a migraine medication advertisement featuring tennis superstar Serena Williams. The FDA’s concerns center around claims
September 14, 2024
No Comments
